Ekso Bionics stock was our first human augmentation recommendation, and it has drifted lower recently.
But the business case for EKSO's growth is very strong.
By Keith Fitz-Gerald, Chief Investment Strategist, Money Map Report -
Ekso Bionics stock was our first human augmentation recommendation, and it has drifted lower recently.
But the business case for EKSO's growth is very strong.
By Keith Fitz-Gerald, Chief Investment Strategist, Money Map Report -
Ekso Bionics stock was our first human augmentation recommendation, and it has drifted lower recently.
But the business case for EKSO's growth is very strong.
EKSO is crushing its rivals and hitting many milestones...